home / stock / igx:cc / igx:cc quote
Last: | $0.295 |
---|---|
Change Percent: | -4.84% |
Open: | $0.31 |
Close: | $0.31 |
High: | $0.31 |
Low: | $0.29 |
Volume: | 27,155 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.295 | $0.31 | $0.31 | $0.31 | $0.29 | 27,155 | 08-02-2022 |
$0.335 | $0.375 | $0.335 | $0.375 | $0.335 | 7,900 | 05-06-2022 |
$0.33 | $0.395 | $0.33 | $0.4 | $0.33 | 36,099 | 05-05-2022 |
$0.34 | $0.355 | $0.34 | $0.435 | $0.34 | 26,355 | 05-04-2022 |
$0.37 | $0.33 | $0.37 | $0.44 | $0.33 | 99,192 | 05-03-2022 |
$0.33 | $0.38 | $0.33 | $0.38 | $0.33 | 28,173 | 05-02-2022 |
$0.375 | $0.34 | $0.375 | $0.375 | $0.33 | 46,918 | 04-29-2022 |
$0.37 | $0.355 | $0.37 | $0.37 | $0.355 | 3,565 | 04-28-2022 |
$0.33 | $0.33 | $0.33 | $0.355 | $0.33 | 26,297 | 04-27-2022 |
$0.33 | $0.33 | $0.33 | $0.33 | $0.33 | 1,195 | 04-26-2022 |
$0.345 | $0.345 | $0.345 | $0.345 | $0.345 | 7,946 | 04-25-2022 |
$0.335 | $0.29 | $0.335 | $0.34 | $0.29 | 14,009 | 04-22-2022 |
$0.35 | $0.305 | $0.35 | $0.35 | $0.305 | 44,589 | 04-21-2022 |
$0.34 | $0.33 | $0.34 | $0.34 | $0.31 | 21,273 | 04-20-2022 |
$0.33 | $0.31 | $0.33 | $0.33 | $0.29 | 57,049 | 04-19-2022 |
$0.32 | $0.32 | $0.32 | $0.32 | $0.31 | 26,767 | 04-18-2022 |
$0.3 | $0.31 | $0.3 | $0.31 | $0.3 | 38,990 | 04-13-2022 |
$0.31 | $0.345 | $0.31 | $0.345 | $0.3 | 58,818 | 04-12-2022 |
$0.33 | $0.33 | $0.33 | $0.33 | $0.31 | 33,978 | 04-11-2022 |
$0.33 | $0.335 | $0.33 | $0.335 | $0.31 | 110,322 | 04-08-2022 |
News, Short Squeeze, Breakout and More Instantly...
Intelgenx Technologies Corp. Company Name:
IGX:CC Stock Symbol:
TSXC Market:
SAINT LAURENT, Quebec, Feb. 21, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that the United States Patent and Trademark Office (“USPTO”) has granted a Notice of Allowanc...
SAINT-LAURENT, Quebec, Feb. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced a research collaboration with Per Svenningsson, MD, PhD, of the Karolinska Institute, to plan and conduct a...
SAINT LAURENT, Quebec, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, announced today that it has entered into an exclusive supply agreement (the “Agreement”) for RIZAPORT ® (th...